Global investment firm TPG has entered into a binding agreement to acquire a 35% stake in SCHOTT Poonawalla Pvt Ltd, a ...

Global investment firm TPG has signed a legally binding agreement to purchase a 35% ownership in SCHOTT Poonawalla, the joint venture between Serum Institute of India (SII) and Germany-based SCHOTT ...

The transaction is subject to customary closing conditions and is expected to close within the first half of 2025.

Global alternative asset firm TPG has acquired a 35% stake in SCHOTT Poonawalla, a joint venture between SCHOTT Pharma and ...

TPG acquires 35% stake in SCHOTT Poonawalla from Serum Institute of India; SCHOTT Pharma retains 50% while SII continues as ...

TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in SCHOTT ...

TPG is acquiring a 35% stake in SCHOTT Poonawalla, a joint venture of SCHOTT Pharma and Serum Institute of India. The deal is ...

TPG is making the investment along with Danish firm Novo Holdings as a co-investor. SII, the world's largest vaccine maker, ...

TPG has entered into a binding agreement to acquire 35% stake in Schott Poonawalla from Serum Institute of India (SII), said ...

TPG will acquire a 35% stake in SCHOTT Poonawalla from the Serum Institute of India. This joint venture with SCHOTT Pharma is ...

TPG Growth, TPG’s middle market and growth equity platform, is funding the investment, along with Novo Holdings as a ...